Cargando…

A New Adjuvant MTOM Mediates Mycobacterium tuberculosis Subunit Vaccine to Enhance Th1-Type T Cell Immune Responses and IL-2(+) T Cells

The only licensed vaccine Mycobacterium bovis Bacillus Calmette–Guérin (BCG) cannot prevent the prevalence of tuberculosis (TB), which remains a major public health problem worldwide. A more effective TB vaccine than BCG is urgently needed. Subunit vaccine is a promising strategy, and suitable adjuv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Qi, Wang, Xiaochun, Fan, Xionglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436497/ https://www.ncbi.nlm.nih.gov/pubmed/28572807 http://dx.doi.org/10.3389/fimmu.2017.00585

Ejemplares similares

Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine
por: Hao, Ling, et al.
Publicado: (2020)

Protection against Mycobacterium tuberculosis Infection Offered by a New Multistage Subunit Vaccine Correlates with Increased Number of IFN-γ(+)IL-2(+) CD4(+) and IFN-γ(+) CD8(+) T Cells
por: Wang, Xiaochun, et al.
Publicado: (2015)

Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against Mycobacterium tuberculosis Infection
por: Ullah, Nadeem, et al.
Publicado: (2020)

Role of Fused Mycobacterium tuberculosis Immunogens and Adjuvants in Modern Tuberculosis Vaccines
por: Junqueira-Kipnis, Ana Paula, et al.
Publicado: (2014)

Formulation in DDA-MPLA-TDB Liposome Enhances the Immunogenicity and Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection
por: Tian, Maopeng, et al.
Publicado: (2018)

Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics
por: Enriquez, Ana B., et al.
Publicado: (2021)

Mycobacterium tuberculosis multistage antigens confer comprehensive protection against pre- and post-exposure infections by driving Th1-type T cell immunity
por: Ma, Jilei, et al.
Publicado: (2016)

Advances in protein subunit vaccines against tuberculosis
por: Zhang, Ying, et al.
Publicado: (2023)

A Multistage Subunit Vaccine Effectively Protects Mice Against Primary Progressive Tuberculosis, Latency and Reactivation
por: Ma, Jilei, et al.
Publicado: (2017)

A novel multistage antigens ERA005f confer protection against Mycobacterium tuberculosis by driving Th-1 and Th-17 type T cell immune responses
por: Fan, Xueting, et al.
Publicado: (2023)

Heterologous Boost Following Mycobacterium bovis BCG Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection
por: Wu, Yaqi, et al.
Publicado: (2018)

IL-10 Overexpression After BCG Vaccination Does Not Impair Control of Mycobacterium tuberculosis Infection
por: Ferreira, Catarina M., et al.
Publicado: (2022)

IL-2 Restores T-Cell Dysfunction Induced by Persistent Mycobacterium tuberculosis Antigen Stimulation
por: Liu, Xun, et al.
Publicado: (2019)

Fusion Cytokines IL-7-Linker-IL-15 Promote Mycobacterium Tuberculosis Subunit Vaccine to Induce Central Memory like T Cell-Mediated Immunity
por: Bai, Chunxiang, et al.
Publicado: (2020)

Corrigendum: IL-2 Restores T-Cell Dysfunction Induced by Persistent Mycobacterium tuberculosis Antigen Stimulation
por: Liu, Xun, et al.
Publicado: (2020)

Lung Tissue Resident Memory T-Cells in the Immune Response to Mycobacterium tuberculosis
por: Ogongo, Paul, et al.
Publicado: (2019)

It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity
por: Larsen, Sasha E., et al.
Publicado: (2022)

Cyclic di-AMP as endogenous adjuvant enhanced BCG-induced trained immunity and protection against Mycobacterium tuberculosis in mice
por: Ning, Huanhuan, et al.
Publicado: (2022)

Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by Pseudomonas aeruginosa
por: Das, Sayan, et al.
Publicado: (2020)

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
por: Zhang, Yandi, et al.
Publicado: (2021)

Regulatory T Cells in Mycobacterium tuberculosis Infection
por: Cardona, Paula, et al.
Publicado: (2019)

Carbohydrate Immune Adjuvants in Subunit Vaccines
por: Bashiri, Sahra, et al.
Publicado: (2020)

IL-1β, But Not Programed Death-1 and Programed Death Ligand Pathway, Is Critical for the Human Th17 Response to Mycobacterium tuberculosis
por: Stephen-Victor, Emmanuel, et al.
Publicado: (2016)

IL-7-Adjuvanted Vaginal Vaccine Elicits Strong Mucosal Immune Responses in Non-Human Primates
por: Logerot, Sandrine, et al.
Publicado: (2021)

Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants
por: Sui, Yongjun, et al.
Publicado: (2023)

The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination
por: Antonio-Herrera, Laura, et al.
Publicado: (2018)

Mycobacterium tuberculosis TlyA Protein Negatively Regulates T Helper (Th) 1 and Th17 Differentiation and Promotes Tuberculosis Pathogenesis*
por: Rahman, Md. Aejazur, et al.
Publicado: (2015)

IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?
por: Zhao, Yue, et al.
Publicado: (2022)

The T-Cell Response to Lipid Antigens of Mycobacterium tuberculosis
por: De Libero, Gennaro, et al.
Publicado: (2014)

Uncovering the Mast Cell Response to Mycobacterium tuberculosis
por: Torres-Atencio, Ivonne, et al.
Publicado: (2022)

Immunity to the Dual Threat of Silica Exposure and Mycobacterium tuberculosis
por: Konečný, Petr, et al.
Publicado: (2019)

Characterization of Mycobacterium tuberculosis–Specific Th22 Cells and the Effect of Tuberculosis Disease and HIV Coinfection
por: Makatsa, Mohau S., et al.
Publicado: (2022)

Inhibiting Histone Deacetylases in Human Macrophages Promotes Glycolysis, IL-1β, and T Helper Cell Responses to Mycobacterium tuberculosis
por: Cox, Donal J., et al.
Publicado: (2020)

Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani
por: Duthie, Malcolm S., et al.
Publicado: (2018)

Respiratory Syncytial Virus F Subunit Vaccine With AS02 Adjuvant Elicits Balanced, Robust Humoral and Cellular Immunity in BALB/c Mice
por: Zheng, Yu, et al.
Publicado: (2020)

Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease
por: Petruccioli, Elisa, et al.
Publicado: (2021)

Recombinant BCG With Bacterial Signaling Molecule Cyclic di-AMP as Endogenous Adjuvant Induces Elevated Immune Responses After Mycobacterium tuberculosis Infection
por: Ning, Huanhuan, et al.
Publicado: (2019)

Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis
por: Sankar, Poornima, et al.
Publicado: (2023)

Immune Responses to Bacillus Calmette–Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis?
por: Moliva, Juan I., et al.
Publicado: (2017)

Mycobacterium tuberculosis EspR modulates Th1-Th2 shift by transcriptionally regulating IL-4, steering increased mycobacterial persistence and HIV propagation during co-infection
por: Yandrapally, Sriram, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9om1e94490shh9e0011tc4o15b